tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AARD Stock Latest News

Aardvark Therapeutics Reports Q3 2025 Financial Results
Company AnnouncementsAardvark Therapeutics Reports Q3 2025 Financial Results
8d ago
AARD
Aardvark Therapeutics reports Q3 EPS (75c), consensus (80c)
PremiumThe Fly
Aardvark Therapeutics reports Q3 EPS (75c), consensus (80c)
13d ago
AARD
Aardvark Thera sees cash, equivalents sufficient to fund operations into 2027
PremiumThe Fly
Aardvark Thera sees cash, equivalents sufficient to fund operations into 2027
13d ago
AARD
Aardvark Therapeutics, Inc.: Undervalued Potential in the Obesity Treatment Market with Promising Pipeline
PremiumRatings
Aardvark Therapeutics, Inc.: Undervalued Potential in the Obesity Treatment Market with Promising Pipeline
16d ago
AARD
Datadog, Trade Desk upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Datadog, Trade Desk upgraded: Wall Street’s top analyst calls
19d ago
U
PI
Aardvark Therapeutics initiated with a Buy at BTIG
PremiumThe FlyAardvark Therapeutics initiated with a Buy at BTIG
19d ago
AARD
Aardvark Therapeutics Hosts Investor Webinar on Drug Programs
Premium
Company Announcements
Aardvark Therapeutics Hosts Investor Webinar on Drug Programs
20d ago
8K
AARD
Promising Potential of Aardvark Therapeutics: Buy Rating Based on ARD-201 and ARD-101 Developments
Premium
Ratings
Promising Potential of Aardvark Therapeutics: Buy Rating Based on ARD-201 and ARD-101 Developments
21d ago
AARD
Aardvark Therapeutics Showcases Obesity Research at ObesityWeek
PremiumCompany Announcements
Aardvark Therapeutics Showcases Obesity Research at ObesityWeek
22d ago
8K
AARD
Aardvark Therapeutics presents data on metabolic obesity pipeline programs
PremiumThe Fly
Aardvark Therapeutics presents data on metabolic obesity pipeline programs
22d ago
AARD
Aardvark Therapeutics Advances PWS Treatment with ARD-101 Study
PremiumCompany Announcements
Aardvark Therapeutics Advances PWS Treatment with ARD-101 Study
30d ago
AARD
Aardvark Therapeutics’ ARD-101 Study: A New Hope for Prader-Willi Syndrome
PremiumCompany Announcements
Aardvark Therapeutics’ ARD-101 Study: A New Hope for Prader-Willi Syndrome
30d ago
AARD
Aardvark Therapeutics Aligns with FDA on Trial Amendment
PremiumCompany AnnouncementsAardvark Therapeutics Aligns with FDA on Trial Amendment
2M ago
8K
AARD
Aardvark Therapeutics announces FDA alignment on HERO trial protocol amendment
Premium
The Fly
Aardvark Therapeutics announces FDA alignment on HERO trial protocol amendment
2M ago
AARD
Aardvark Therapeutics initiated with a Buy at JonesResearch
Premium
The Fly
Aardvark Therapeutics initiated with a Buy at JonesResearch
2M ago
AARD
Promising Clinical Developments and Strategic Positioning Drive Buy Rating for Aardvark Therapeutics
PremiumRatings
Promising Clinical Developments and Strategic Positioning Drive Buy Rating for Aardvark Therapeutics
2M ago
AARD
Aardvark Therapeutics initiated with a Buy at Stifel
PremiumThe Fly
Aardvark Therapeutics initiated with a Buy at Stifel
2M ago
AARD
Buy Rating for Aardvark Therapeutics: ARD-101’s Potential in Prader-Willi Syndrome Treatment
PremiumRatings
Buy Rating for Aardvark Therapeutics: ARD-101’s Potential in Prader-Willi Syndrome Treatment
2M ago
AARD
Aardvark Therapeutics: Undervalued Opportunity in Obesity Treatment Market with Promising Pipeline and Upcoming Catalysts
PremiumRatings
Aardvark Therapeutics: Undervalued Opportunity in Obesity Treatment Market with Promising Pipeline and Upcoming Catalysts
2M ago
AARD
Aardvark Therapeutics reports inducement grants under Nasdaq listing rule
PremiumThe FlyAardvark Therapeutics reports inducement grants under Nasdaq listing rule
3M ago
AARD
Aardvark Therapeutics Updates Corporate Presentation on Strategy
Premium
Company Announcements
Aardvark Therapeutics Updates Corporate Presentation on Strategy
3M ago
8K
AARD
Aardvark Therapeutics price target lowered to $25 from $26 at BofA
Premium
The Fly
Aardvark Therapeutics price target lowered to $25 from $26 at BofA
3M ago
AARD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >